Bristol Myers Squibb Co. (BMY)

55.26 -1.36 (-2.40%) USD  |  NYSE  |  Jan 16, 16:00
55.30 +0.04 (+0.07%) After-Hours: 20:00
More

Bristol Myers Squibb Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Assets (Quarterly) Benchmarks

View Long Term Deferred Assets (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade